<p>Groups of 7 or 10 CD1 mice received immune sera from (<b>A</b>) CD1 mice, (<b>B</b>) guinea pigs or (<b>C</b>) humans and survival was monitored for 14 days. Shown are the mean % of surviving animals each day following lethal challenge. Reciprocal neutralizing antibody titers shown are the means extrapolated from titers measured immediately prior to challenge. N = Naive serum. All mice receiving mouse immune sera of mean titer ≥1∶16 and guinea pig immune sera of mean titer ≥ 1∶43 were protected.</p
<p>At day 42, vaccinated mice were challenged intranasally with a lethal dose (100 LD<sub>50</sub>) ...
<p>Mice (n = 10/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged in...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Data points represent the mean % of surviving animals 14 days following lethal challenge of CD1 m...
<p>(A) Mice (n = 8/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before ...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>Shown are reciprocal MN titers:</p>a<p>expected titer based on the volume and titer of injected i...
<p>Groups of eight mice that received a single dose of 10<sup>6</sup> TCID<sub>50</sub> of the H5N1 ...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<p>SCID mice were challenged with 10<sup>5</sup> TCID<sub>50</sub> pandemic H1N1 (H1N1 A/California/...
Vero cell culture-derived whole-virus H5N1 vaccines have been extensively tested in clinical trials ...
<p>Female BALB/c mice (6−8 wk old, five mice per group) were intramuscularly immunized with 20 µg of...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Mice were challenged one month after vaccination (0.5 µg PZQ/0.1 µg antigen). (A) Viral loads in ...
<p>Mice (n = 8-10/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before c...
<p>At day 42, vaccinated mice were challenged intranasally with a lethal dose (100 LD<sub>50</sub>) ...
<p>Mice (n = 10/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged in...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Data points represent the mean % of surviving animals 14 days following lethal challenge of CD1 m...
<p>(A) Mice (n = 8/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before ...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>Shown are reciprocal MN titers:</p>a<p>expected titer based on the volume and titer of injected i...
<p>Groups of eight mice that received a single dose of 10<sup>6</sup> TCID<sub>50</sub> of the H5N1 ...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<p>SCID mice were challenged with 10<sup>5</sup> TCID<sub>50</sub> pandemic H1N1 (H1N1 A/California/...
Vero cell culture-derived whole-virus H5N1 vaccines have been extensively tested in clinical trials ...
<p>Female BALB/c mice (6−8 wk old, five mice per group) were intramuscularly immunized with 20 µg of...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Mice were challenged one month after vaccination (0.5 µg PZQ/0.1 µg antigen). (A) Viral loads in ...
<p>Mice (n = 8-10/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before c...
<p>At day 42, vaccinated mice were challenged intranasally with a lethal dose (100 LD<sub>50</sub>) ...
<p>Mice (n = 10/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged in...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...